Skip to content

Common Stock at other companies

Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
120M0.0%
Replimune Group logo
Replimune GroupREPL
150M0.0%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$9K0.0%
Erasca, Inc. logo
Erasca, Inc.ERAS
$31K+10.7%
Arcus Biosciences logo
Arcus BiosciencesRCUS
400M0.0%
Tango Therapeutics logo
Tango TherapeuticsTNGX
400M+100%

Other financials

Income statement

See full
Revenue-
Operating income-$15.6M+8.1%
Net income-$15.2M+4.8%
EPS (diluted)-$1.11+6.7%

Balance sheet

See full
Cash & equivalents$192.1M+98.7%
Total debt$409.0K-57.2%
Total equity$184.4M+103%
Total assets$198.7M+98.9%

Cash flow

See full
Operating cash flow-$12.9M+7.6%
CapEx$5.0K-72.2%
Free cash flow-$12.9M+7.7%

Valuation

See full
Market cap$184.2M+72.6%
Enterprise value-$7.49M-127%

Returns & leverage

See full
Return on equity-42.7%
Debt / equity0.0×
Current ratio13.8×+2.6×

Where this comes from

Reported directly by OnKure Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: OnKure Therapeutics, Inc.’s 10-Q, filed November 7, 2024, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s common stock?
OnKure Therapeutics, Inc. (OKUR) reported common stock of $0 in Q3 2024.
How has OnKure Therapeutics, Inc.'s common stock changed year-over-year?
OnKure Therapeutics, Inc.'s common stock decreased by 100.0% year-over-year, from $3K to $0.
What is the long-term trend for OnKure Therapeutics, Inc.'s common stock?
Over 2 years (2021 to 2023), OnKure Therapeutics, Inc.'s common stock has grown at a -100.0% compound annual growth rate (CAGR), from $3K to $0.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).